Cargando…
CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer’s disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, and is the most common type of cognitive impairment and dementia. There is a pressing need to improve the clinical efficacy and quality of life for AD patients, as limited treatments options for AD patients have been developed unt...
Autores principales: | Liu, Zehui, Wang, Wanyan, Huang, Tingyu, Wang, Cunfang, Huang, Ying, Tang, Yong, Huang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756745/ https://www.ncbi.nlm.nih.gov/pubmed/31545823 http://dx.doi.org/10.1371/journal.pone.0222757 |
Ejemplares similares
-
Cerebroprotein hydrolysate attenuates neurodegenerative changes in Alzheimer’s mice model via ferroptosis pathway
por: Chen, Moxi, et al.
Publicado: (2023) -
Cerebroprotein hydrolysate‐I protects senescence‐induced by D‐galactose in PC12 cells and mice
por: Zhu, Lin, et al.
Publicado: (2021) -
Troxerutin and Cerebroprotein Hydrolysate Injection Protects Neurovascular Units from Oxygen-Glucose Deprivation and Reoxygenation-Induced Injury In Vitro
por: Zhào, Hóngyi, et al.
Publicado: (2018) -
Transcriptome Analysis Reveals the Effects of Troxerutin and Cerebroprotein Hydrolysate Injection on Injured Spinal Cords in Rats
por: Wang, Linbang, et al.
Publicado: (2020) -
Protective effect of troxerutin and cerebroprotein hydrolysate injection on cerebral ischemia through inhibition of oxidative stress and promotion of angiogenesis in rats
por: Ma, Wenbing, et al.
Publicado: (2019)